MicroRNA-210 and endoplasmic reticulum chaperones in the regulation of chemoresistance in glioblastoma

Journal of Cancer

Volumn 6, Issue 3, 2015, Pages 227-232

  Lee, Derek ^a   Sun, Stella ^a   Zhang, Xiao Qin ^a   De Zhang, Ping ^a   Ho, Amy S W ^a   Kiang, Karrie M Y ^a   Fung, Ching Fai ^a   Lui, Wai Man ^a   Leung, Gilberto K K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chemoresistance; ER stress reponse; Glioblastoma; miRNA; P4HB; Temozolomide

Indexed keywords

MICRORNA 210; POLYPEPTIDE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE BETA POLYPEPTIDE; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER RESISTANCE; CELL PROLIFERATION ASSAY; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 84923690260     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.10765     Document Type: Article

References (23)

1. Ohgaki H. Epidemiology of brain tumors. Methods Mol Biol. 2009; 472: 323-42.
2. Fisher JL, Schwartzbaum JA, Wrensch M, et al. Epidemiology of brain tumors. Neurol Clin. 2007; 25: 867-90, vii.
3. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114: 97-109.
4. Sun S, Lee D, Lee NP, et al. Hyperoxia resensitizes chemoresistant human glioblastoma cells to temozolomide. J Neurooncol. 2012; 109: 467-75.
5. Ni M, Lee AS. ER chaperones in mammalian development and human diseases. FEBS Lett. 2007; 581: 3641-51.
6. Fu Y, Li J, Lee AS. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Cancer Res. 2007; 67: 3734-40.
7. Sun S, Wong TS, Zhang XQ, et al. Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines. J Neurooncol. 2012; 107: 89-100.
8. Ahmed R, Oborski MJ, Hwang M, et al. Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods. Cancer Manag Res. 2014; 6: 149-70.
9. Ambros V, Bartel B, Bartel DP, et al. A uniform system for microRNA annotation. Rna. 2003; 9: 277-9.
10. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-97.
11. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101: 2999-3004.
12. Lai NS, Dong QS, Ding H, et al. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients. J Clin Neurosci. 2014; 21: 755-60.
13. Lee D, Sun S, Ho AS, et al. Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through unfolded protein response. Anticancer Res. 2014; 34: 2957-66.
14. Fasanaro P, Greco S, Lorenzi M, et al. An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem. 2009; 284: 35134-43.
15. Sun S, Lee D, Ho AS, et al. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways. Neuro Oncol. 2013; 15: 562-77.
16. Huang X, Le QT, Giaccia AJ. MiR-210--micromanager of the hypoxia pathway. Trends Mol Med. 2010; 16: 230-7.
17. Zhu XM, Han T, Sargent IL, et al. Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol. 2009; 200: 661 e1-7.
18. Pineles BL, Romero R, Montenegro D, et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol. 2007; 196: 261 e1-6.
19. Giannakakis A, Sandaltzopoulos R, Greshock J, et al. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol Ther. 2008; 7: 255-64.
20. Wyman SK, Parkin RK, Mitchell PS, et al. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS One. 2009; 4: e5311.
21. Huang X, Ding L, Bennewith KL, et al. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell. 2009; 35: 856-67.
22. McCormick RI, Blick C, Ragoussis J, et al. miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis. Br J Cancer. 2013; 108: 1133-42.
23. Mei Y, Gao C, Wang K, et al. Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia. Cancer Sci. 2014; 105: 463-72.